Skip to search formSkip to main contentSkip to account menu

trapoxin A

Known as: Cyclo((S)-phenylalanyl-(S)-phenylalanyl-(R)-pipecolinyl-(2S,9S)-2-amino-8-oxo-9,10-epoxydecanoyl), Cyclo((S)-gamma-oxo-L-alpha-aminooxiraneoctanoyl-L-phenylalanyl-L-phenylalanyl-D-2-piperidinecarbonyl), Trapoxin 
An epoxide-containing cyclotetrapeptide with antitumor activity. It is an irreversible inhibitor of histone deacetylase.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Abstract Back ground Adipose tissue derived mesenchymal stem cells (ASCs) have unique potential for regenerative cell therapies… 
2008
2008
Naturally occurring cyclic tetrapeptides (CTPs) such as tentoxin (Halloin et al., Plant Physiol 1970, 45, 310–314; Saad… 
Review
2008
Review
2008
Histone deacetylase (HDAC) inhibitors, such as trichostatin A and trapoxin, which were first found in microorganisms, potently… 
1999
1999
ABSTRACT We previously reported that the activation of the M promoter of the human choline acetyltransferase (ChAT) gene by… 
1998
1998
Histone acetylation levels in cells result from a dynamic equilibrium between competing histone acetylases and deacetylases… 
Highly Cited
1997
Highly Cited
1997
The short-chain fatty acid butyrate has been shown to elevate fetal hemoglobin (HbF) by inducing expression of the gamma-globin… 
1997
1997
The short-chain fatty acid butyrate has been shown to eleement spanning the duplicated CCAAT box region of the gglobin promoter…